Group One Trading’s Bicara Therapeutics BCAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6,000
Closed -$178K – 8538
2026
Q2
$178K Buy
+6,000
New +$134K ﹤0.01% 4378
2026
Q1
– Sell
-100
Closed -$1.68K – 9003
2025
Q4
$1.68K Hold
100
– – ﹤0.01% 7604
2025
Q3
$1.58K Buy
+100
New +$1.12K ﹤0.01% 7964

Other funds holding BCAX

Group One Trading's BCAX Position: Q3 2026 in Review

Group One Trading opened a new position in Bicara Therapeutics (BCAX) in Q3 2026: 4,090 shares worth $76.1K. The stake represents ﹤0.01% of the portfolio and ranks #4937 among its holdings. This is a return to the name: Group One Trading previously reported a position in BCAX as recently as Q1 2026.

Group One Trading first reported a position in BCAX in Q4 2025 and has held it in 3 quarters since. The position peaked at $285K in Q4 2025. 169 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.

  • Group One Trading held 4,090 shares of Bicara Therapeutics worth $76.1K as of Q3 2026.
  • Bicara Therapeutics was a new Group One Trading position in Q3 2026.
  • Bicara Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #4937 holding.
  • Group One Trading first reported a position in Bicara Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Group One Trading's Bicara Therapeutics position peaked at $285K in Q4 2025.
  • 169 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.